MARKET

MBX

MBX

MBX Biosciences Inc
NASDAQ
32.45
-2.91
-8.23%
After Hours: 32.45 0 0.00% 17:51 05/15 EDT
OPEN
34.87
PREV CLOSE
35.36
HIGH
35.27
LOW
32.00
VOLUME
606.38K
TURNOVER
--
52 WEEK HIGH
45.85
52 WEEK LOW
9.43
MARKET CAP
1.54B
P/E (TTM)
-14.6959
1D
5D
1M
3M
1Y
5Y
1D
LifeSci Capital Remains a Buy on MBX Biosciences, Inc. (MBX)
TipRanks · 14m ago
MBX Biosciences Advances Obesity And PBH Pipeline As Shares Surge
Simply Wall St · 2d ago
MBX Biosciences price target raised to $56 from $50 at Stifel
TipRanks · 3d ago
MBX Biosciences Is Maintained at Overweight by Barclays
Dow Jones · 4d ago
Barclays Maintains Overweight on MBX Biosciences, Raises Price Target to $70
Benzinga · 4d ago
MBX Biosciences Is Maintained at Market Outperform by Citizens
Dow Jones · 4d ago
Citizens Maintains Market Outperform on MBX Biosciences, Raises Price Target to $86
Benzinga · 4d ago
MBX Biosciences, Inc. (MBX) Receives a Buy from Oppenheimer
TipRanks · 4d ago
More
About MBX
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. It has built its proprietary Precision Endocrine Peptide platform to develop precision peptide therapies that are designed to overcome key limitations of current peptide therapies. Its product candidates and programs include MBX 2109, MBX 1416 and Obesity portfolio. MBX 2109 is a parathyroid hormone peptide prodrug that is designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism. MBX 1416 is designed to be a long-acting glucagon-like peptide-1 (GLP-1), receptor antagonist, as a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. MBX 4291 is designed to be a long-acting and highly potent GLP-1 and glucose-dependent insulinotropic polypeptide, receptor co-agonist prodrug.

Webull offers MBX Biosciences, Inc. stock information, including NASDAQ: MBX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MBX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MBX stock methods without spending real money on the virtual paper trading platform.